Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study
Cureus · 01.07.2026
DOI: 10.7759/cureus.111872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 01.07.2026. Verfasst von J Hari Prasath und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Apollo First Med Hospitals, Chennai, IND. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Apollo First Med Hospitals, Chennai, IND.
- Endocrinology and Diabetes, Pushpanjali Hospital and Research Centre, Agra, IND.
- Cardiology, Shalini Heart Hospital, Nizamabad, IND.
- Endocrinology, Arya Wellness Centre, Guwahati, IND.
- Endocrinology, Dispur Polyclinic and Hospitals, Guwahati, IND.
- Endocrinology and Diabetes, Singhal Clinic, Kashipur, IND.
Zitieren
APA
Prasath, J. H., Garg, U., Kurapati, K., Baro Agarwal, A., Singhal, P., Anthuvan, T., Gadia, S., Gupta, A., & B, S. S. (2026). Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study. Cureus. https://doi.org/10.7759/cureus.111872
Vancouver
Prasath JH, Garg U, Kurapati K, Baro Agarwal A, Singhal P, Anthuvan T, et al. Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study. Cureus. 2026. doi:10.7759/cureus.111872
BibTeX
@article{Prasath2026,
author = {Prasath, J Hari and Garg, Umesh and Kurapati, Kalyan and Baro Agarwal, Abhamoni and Singhal, Parul and Anthuvan, Thamburaj and Gadia, Smriti and Gupta, Amit and B, Sridhar S},
title = {Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111872}
}
EUVIMED